This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
A zero-spend month concentrates spending to essentials, directing more money toward debt. Plan, track, and celebrate smaller, steady wins.
15,981 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Stocks jumped after President Trump signaled possible de-escalation with Iran, fueling a risk-on rally. Yet analysts ...
A caller in his 60s with a six-figure income and no retirement savings since 2008 receives a blunt reality check on T...
Two Nevada lawmakers demand a comprehensive plan to fix safety oversight gaps tied to Elon Musk's Boring Co. tunnelin...
Startale Group announces a $63 million Series A backed by SBI Group and Sony Innovation Fund to accelerate Strium, it...
As recession fears swirl, long-duration U.S. Treasuries offer a potential ballast. The TLT ETF is drawing interest as...
Disney's stock is under renewed pressure as its core businesses face slower growth. The market is awaiting clearer pr...
When markets wobble, resilient essentials stocks shine. Meet three proven picks that have stood the test of time: Pro...
Horizon (HRZN) investors want clarity on Q3 2025 results and what comes next. This article breaks down horizon (hrzn)...
Two-thirds of the S&P 500 have reported, and the results are surprisingly strong. This could mean smoother gains for ...
Strategic ambiguity around Bitcoin holdings prompted fresh market jitters as Michael Saylor hinted at selling a porti...
Three EV peers face a common challenge: turn bold promises into durable profits. This guide compares Tesla, Rivian, a...